Multiple Severe Toxicities of L-Asparaginase and Their Innovative Management during Induction Therapy of Acute Lymphoblastic Leukemia in an Adult Patient

por Beziat, Guillaume, Tavitian, Suzanne, Picard, Muriel, Faguer, Stanislas, Recher, Christian, Huguet, Françoise
Publicado 2019

An ETV6::NTRK3 fusion transcript in a core‐binding factor acute myeloid leukemia

por Coster, Lucie, Huguet, Françoise, Canali, Alban, Rieu, Jean‐Baptiste, De Mas, Véronique Mansat‐
Publicado 2023

Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France

por Pajiep, Marie, Conte, Cécile, Huguet, Françoise, Gauthier, Martin, Despas, Fabien, Lapeyre-Mestre, Maryse
Publicado 2021

A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia in Third-Line Treatme...

por Nicolini, Franck-Emmanuel, Huguet, Françoise, Huynh, Lynn, Xu, Churong, Bouvier, Christophe, Yocolly, Aurore, Etienne, Gabriel
Publicado 2023

Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience

por Bertoli, Sarah, Tavitian, Suzanne, Bories, Pierre, Luquet, Isabelle, Delabesse, Eric, Comont, Thibault, Sarry, Audrey, Huguet, Françoise, Bérard, Emilie, Récher, Christian
Publicado 2019

P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A...

por Chantepie, Sylvain, Huguet, Françoise, Hunault, Mathilde, Roth Guepin, Gabrielle, Balsat, Marie, Pilar Gallego Hernanz, Maria, Joris, Magalie, Karangwa, Alexandre, Ojeda Uribe, Mario, Santagostino, Alberto, Maury, Sébastien
Publicado 2023

Prognostic impact of viral reactivations in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation in first complete response

por Guenounou, Sarah, Borel, Cécile, Bérard, Emilie, Yon, Edwige, Fort, Marylise, Mengelle, Catherine, Bertoli, Sarah, Sarry, Audrey, Tavitian, Suzanne, Huguet, Françoise, Attal, Michel, Récher, Christian, Huynh, Anne
Publicado 2016

Improved outcome for AML patients over the years 2000–2014

por Bertoli, Sarah, Tavitian, Suzanne, Huynh, Anne, Borel, Cécile, Guenounou, Sarah, Luquet, Isabelle, Delabesse, Eric, Sarry, Audrey, Laurent, Guy, Attal, Michel, Huguet, Françoise, Bérard, Emilie, Récher, Christian
Publicado 2017

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies

por Bertoli, Sarah, Sterin, Arthur, Tavitian, Suzanne, Oberic, Lucie, Ysebaert, Loïc, Bouabdallah, Reda, Vergez, François, Sarry, Audrey, Bérard, Emilie, Huguet, Françoise, Laurent, Guy, Prébet, Thomas, Vey, Norbert, Récher, Christian
Publicado 2016

Monitoring of asparagine depletion and anti-l-asparaginase antibodies in adult acute lymphoblastic leukemia treated in the pediatric-inspired GRAALL-2005 trial

por Paillassa, Jérôme, Leguay, Thibaut, Thomas, Xavier, Huguet, Françoise, Audrain, Marie, Lheritier, Véronique, Vianey-Saban, Christine, Acquaviva-Bourdain, Cécile, Pagan, Cécile, Dombret, Hervé, Ifrah, Norbert, Boissel, Nicolas, Hunault-Berger, Mathilde
Publicado 2018

Vitamin C and D supplementation in acute myeloid leukemia

por Mouchel, Pierre Luc, Bérard, Emilie, Tavitian, Suzanne, Gadaud, Noémie, Vergez, François, Rieu, Jean Baptiste, Luquet, Isabelle, Sarry, Audrey, Huguet, Françoise, Largeaud, Laetitia, Delabesse, Eric, Huynh, Anne, Bertoli, Sarah, Récher, Christian
Publicado 2023

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies

por Tavitian, Suzanne, Peron, Jean-Marie, Huguet, Françoise, Kamar, Nassim, Abravanel, Florence, Beyne-Rauzy, Odile, Oberic, Lucie, Faguer, Stanislas, Alric, Laurent, Roussel, Murielle, Gaudin, Clément, Ysebaert, Loïc, Huynh, Anne, Recher, Christian
Publicado 2015

Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia

por Dumas, Pierre-Yves, Bertoli, Sarah, Bérard, Emilie, Médiavilla, Clémence, Yon, Edwige, Tavitian, Suzanne, Leguay, Thibaut, Huguet, Françoise, Forcade, Edouard, Milpied, Noël, Sarry, Audrey, Sauvezie, Mathieu, Bories, Pierre, Pigneux, Arnaud, Récher, Christian
Publicado 2017

CD34(+)CD38(−)CD123(+) Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents

por Vergez, François, Nicolau-Travers, Marie-Laure, Bertoli, Sarah, Rieu, Jean-Baptiste, Tavitian, Suzanne, Bories, Pierre, Luquet, Isabelle, De Mas, Véronique, Largeaud, Laetitia, Sarry, Audrey, Huguet, Françoise, Delabesse, Eric, Bérard, Emilie, Récher, Christian
Publicado 2020

Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia

por Touzart, Aurore, Boissel, Nicolas, Belhocine, Mohamed, Smith, Charlotte, Graux, Carlos, Latiri, Mehdi, Lhermitte, Ludovic, Mathieu, Eve-Lyne, Huguet, Françoise, Lamant, Laurence, Ferrier, Pierre, Ifrah, Norbert, Macintyre, Elizabeth, Dombret, Hervé, Asnafi, Vahid, Spicuglia, Salvatore
Publicado 2020

Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib

por Genthon, Alexis, Nicolini, Franck Emmanuel, Huguet, Françoise, Colin-Gil, Carole, Berger, Marc, Saugues, Sandrine, Janel, Alexandre, Hayette, Sandrine, Cohny-Makhoul, Pascale, Cadoux, Nadine, Cayuela, Jean-Michel, Campos, Lydia, Guyotat, Denis, Flandrin-Gresta, Pascale
Publicado 2020

Genomic landscape of hyperleukocytic acute myeloid leukemia

por Largeaud, Laetitia, Bertoli, Sarah, Bérard, Emilie, Tavitian, Suzanne, Picard, Muriel, Dufrechou, Stéphanie, Prade, Naïs, Vergez, François, Rieu, Jean Baptiste, Luquet, Isabelle, Sarry, Audrey, Huguet, Françoise, Ruiz, Jean, De Mas, Véronique, Delabesse, Eric, Récher, Christian
Publicado 2022

High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL

por Cabannes-Hamy, Aurélie, Brissot, Eolia, Leguay, Thibaut, Huguet, Françoise, Chevallier, Patrice, Hunault, Mathilde, Escoffre-Barbe, Martine, Cluzeau, Thomas, Balsat, Marie, Nguyen, Stéphanie, Pasquier, Florence, Alexis, Magda, Lhéritier, Véronique, Pastoret, Cédric, Delabesse, Eric, Clappier, Emmanuelle, Dombret, Hervé, Boissel, Nicolas
Publicado 2022

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience

por LaRochelle, Olivier, Bertoli, Sarah, Vergez, François, Sarry, Jean-Emmanuel, Mansat-De Mas, Véronique, Dobbelstein, Sophie, Dastugue, Nicole, Strzelecki, Anne-Claire, Cavelier, Cindy, Creancier, Laurent, Pillon, Arnaud, Kruczynski, Anna, Demur, Cécile, Sarry, Audrey, Huguet, Françoise, Huynh, Anne, Récher, Christian, Delabesse, Eric
Publicado 2011

DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia

por Bond, Jonathan, Touzart, Aurore, Leprêtre, Stéphane, Graux, Carlos, Bargetzi, Mario, Lhermitte, Ludovic, Hypolite, Guillaume, Leguay, Thibaut, Hicheri, Yosr, Guillerm, Gaëlle, Bilger, Karin, Lhéritier, Véronique, Hunault, Mathilde, Huguet, Françoise, Chalandon, Yves, Ifrah, Norbert, Macintyre, Elizabeth, Dombret, Hervé, Asnafi, Vahid, Boissel, Nicolas
Publicado 2019